Bicycle Therapeutics Limited BCYC 深 滬
交易中 07-21 11:32:04 美东时间
8.70
+0.140
+1.64%
華盛通- 最 高9.0702
- 今 開8.77
- 成交量 7.11万股
- 最 低 8.68
- 昨 收 8.56
- 總市值 6.03亿
- 52周最高 28.6701
- 市盈率 靜 --
- 換手率 0.10%
- 52周最低 6.10
- 委 比 -86.05%
- 總股本 6925.39万
- 歷史最高 62.075
- 量 比 0.96
- 振 幅 4.56%
- 歷史最低 6.10
- 每 手 1
- 風險率 6.93%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Demystifying Bicycle Therapeutics: Insights From 7 Analyst Reviews
Bicycle Therapeutics (NASDAQ:BCYC) underwent analysis by 7 analysts in the last...
07-18 06:01
RBC Capital Maintains Outperform on Bicycle Therapeutics, Lowers Price Target to $25
RBC Capital analyst Leonid Timashev maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Outperform and lowers the price target from $32 to $25.
07-17 22:07
Is Bicycle Therapeutics (NASDAQ:BCYC) In A Good Position To Invest In Growth?
Even when a business is losing money, it's possible for shareholders to make mo...
07-14 19:29
Bicycle Therapeutics reports Q1 results
Bicycle Therapeutics press release (NASDAQ:BCYC): Q1 GAAP EPS of -$0.88 Revenue of $10M (-48.8% Y/Y). Cash and cash equivalents were $793.0 million as of March 31, 2025, compared to $879.5 million as ...
05-01 22:14
美股大行评级 | 超多美股遭下调评级！高盛：下调美国航空集团评级至"卖出"，目标价从16美元下调至8美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1117013356914663424.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持FTC Solar(FTCI)"买入"评级，目标价从1.5美元升至5美元</p> <p>• 摩根士丹利：维持艾伯维(ABBV)"超配"评级，目标价从239美元升至241美
04-10 09:00
Bicycle Therapeutics Announces Key Leadership Changes
The latest announcement is out from Bicycle Therapeutics ( ($BCYC) ). Bicycle T...
03-27 20:28
美股大行评级 | Stifel：维持Agilon Health"持有"评级，目标价从2美元升至3美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1101791398596456448.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler：维持Prothena Corp(PRTA)"超配"评级，目标价从94美元升至110美元</p> <p>• HC Wainwright & Co.：维持Karyopharm Therape
02-27 11:06
Deep Dive Into Bicycle Therapeutics Stock: Analyst Perspectives (9 Ratings)
9 analysts have shared their evaluations of Bicycle Therapeutics (NASDAQ:BCYC) ...
02-27 04:01
美股大行评级 | 潜在涨幅189%！Amprius Technologies获机构首予"超配"评级，目标价10美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1089140178661773312.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Truist Securities：维持Praxis Precision Medicine(PRAX)"买入"评级，目标价从150美元升至175美元</p> <p>• 蒙特利尔银行：维持Replimune Group(RE
01-23 11:24
Forecasting The Future: 11 Analyst Projections For Bicycle Therapeutics
Across the recent three months, 11 analysts have shared their insights on Bicyc...
01-14 06:00
